Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomised trial.

[1]  Søren M Bentzen,et al.  High-tech in radiation oncology: should there be a ceiling? , 2004, International journal of radiation oncology, biology, physics.

[2]  David J Brenner,et al.  Hypofractionation for prostate cancer radiotherapy--what are the issues? , 2003, International journal of radiation oncology, biology, physics.

[3]  J. Yarnold,et al.  19 Fractionation sensitivity of breast cancer. Results of a randomised trial , 2003 .

[4]  P. Hoskin,et al.  Survey of UK breast radiotherapy techniques: background prior to the introduction of the quality assurance programme for the START (standardisation of radiotherapy) trial in breast cancer. , 2002, Clinics in oncology.

[5]  Anthony Fyles,et al.  Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer. , 2002, Journal of the National Cancer Institute.

[6]  A. Ruifrok,et al.  Repair capacity and kinetics for human mucosa and epithelial tumors in the head and neck: clinical data on the effect of changing the time interval between multiple fractions per day in radiotherapy. , 1996, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[7]  R. Winkelmann,et al.  Pseudosclerodermatous panniculitis after irradiation: an unusual complication of megavoltage treatment of breast carcinoma. , 1993, Mayo Clinic proceedings.

[8]  P Okunieff,et al.  Clinical implications of heterogeneity of tumor response to radiation therapy. , 1992, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[9]  J R Yarnold,et al.  Cosmetic and functional outcomes of breast conserving treatment for early stage breast cancer. 1. Comparison of patients' ratings, observers' ratings, and objective assessments. , 1992, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[10]  N. Aaronson,et al.  Cosmetic and functional outcomes of breast conserving treatment for early stage breast cancer. 2. Relationship with psychosocial functioning. , 1992, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[11]  J. Yarnold,et al.  Selective avoidance of lymphatic radiotherapy in the conservative management of women with early breast cancer. , 1992, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[12]  J. Henk.  Hypofractionation: lessons from complications. , 1991, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[13]  H D Thames,et al.  Time-dose factors in radiotherapy: a review of the human data. , 1990, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[14]  T. Bates.  Hypofractionation and the therapeutic ratio. , 1989, International journal of radiation oncology, biology, physics.

[15]  J. Fowler.  The linear-quadratic formula and progress in fractionated radiotherapy. , 1989, The British journal of radiology.

[16]  J. Moore,et al.  The high steepness of dose-response curves for late-responding normal tissues. , 1989, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[17]  B. Douglas,et al.  Novel fractionation schemes and high linear energy transfer. , 1984, Progress in experimental tumor research.

[18]  Bruce G. Douglasggg.  Superfractionation: its rationale and anticipated benefits , 1982 .

[19]  B. Douglas.  Superfractionation: its rationale and anticipated benefits. , 1982, International journal of radiation oncology, biology, physics.

[20]  L. Cohen.  I. The Dose-time Relationship: Theoretical Considerations , 1952 .

[21]  L. Cohen.  Radiotherapy in breast cancer. I. The dose-time relationship theoretical considerations. , 1952, The British journal of radiology.